Hansoh Pharmaceutical Group Co Ltd
3KY
Company Profile
Business description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
Contact
No. 287 Xiangke Road
Pudong New Area
Shanghai
CHNT: +86 4008285227
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
9,347
Stocks News & Analysis
stocks
5 star fully franked ASX dividend payer
Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks
An undervalued stock to buy that even Warren Buffett likes
Trading at an 18% discount, this wide-moat stock is a rare find.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,869.10 | 18.40 | 0.21% |
| CAC 40 | 8,078.48 | 0.68 | 0.01% |
| DAX 40 | 25,374.42 | 34.22 | -0.13% |
| Dow JONES (US) | 51,481.51 | 347.11 | -0.67% |
| FTSE 100 | 10,684.88 | 10.37 | -0.10% |
| HKSE | 24,642.51 | 132.42 | 0.54% |
| NASDAQ | 26,820.38 | 248.34 | -0.92% |
| Nikkei 225 | 65,070.58 | 807.04 | -1.23% |
| NZX 50 Index | 13,718.42 | 112.26 | -0.81% |
| S&P 500 | 7,683.69 | 59.72 | -0.77% |
| S&P/ASX 200 | 8,694.50 | 14.80 | 0.17% |
| SSE Composite Index | 3,823.44 | 0.18 | -0.00% |